Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting the neutrophil-DPP-1-protease axis in airway disease: current evidence and future indications.

Respiratory medicine·2026

Same author

Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort.

Journal of personalized medicine·2026

Same author

Immunostimulant-induced maturation of monocyte-derived dendritic cells in respiratory infection prophylaxis.

Drugs in context·2026

Same author

Psychometric Validation of the Speed of Change in Feeling of Health (SCFH) Questionnaire: Findings from the NEWTON Sub-Study in Italian Asthma Patients.

Patient related outcome measures·2026

Same author

Optimizing Respiratory Care with NEXThaler: Bridging Technology and Treatment.

Medical devices (Auckland, N.Z.)·2026

Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026

Same journal

Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatment.

Allergology international : official journal of the Japanese Society of Allergology·2026

Same journal

Distinct peripheral coagulation-fibrinolysis profiles in eosinophilic and non-eosinophilic chronic rhinosinusitis.

Allergology international : official journal of the Japanese Society of Allergology·2026

Same journal

Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial.

Allergology international : official journal of the Japanese Society of Allergology·2026

Same journal

Distinct allergen-specific T cell receptor clonotypes drive divergent immune programs in a cloned mouse model of atopic dermatitis.

Allergology international : official journal of the Japanese Society of Allergology·2026

Same journal

Short-chain fatty acids modulate the development and the cell surface molecule expression of DCs by epigenetic regulation.

Allergology international : official journal of the Japanese Society of Allergology·2026

Same journal

Skin symptoms during the pollen seasons and their association with the severity of seasonal allergic rhinitis in Yamanashi, Japan.

Allergology international : official journal of the Japanese Society of Allergology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 5, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Sublingual immunotherapy: recent advances.

Enrico Compalati¹, Fulvio Braido, Giorgio Walter Canonica

¹Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, Genoa, Italy.

Allergology International : Official Journal of the Japanese Society of Allergology

|November 28, 2013

Summary

This summary is machine-generated.

Sublingual immunotherapy (SLIT) is increasingly used for respiratory allergies due to proven efficacy and safety. Further research is needed to optimize patient selection and improve adherence to this treatment.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Related Experiment Videos

Last Updated: May 5, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Area of Science:

Immunology
Allergology
Pharmacology

Background:

Sublingual immunotherapy (SLIT) for respiratory allergies is increasingly adopted globally.
Recent high-quality studies confirm its clinical efficacy and safety in various populations.
Preliminary evidence suggests benefits for perennial allergens and asthma.

Purpose of the Study:

To review the current status and future potential of SLIT.
To discuss advancements in SLIT formulations and delivery.
To highlight challenges in patient selection and treatment adherence.

Main Methods:

Review of recent high-powered clinical trials and meta-analyses.
Examination of emerging research on perennial allergens and asthma.
Analysis of novel SLIT formulation strategies.

Main Results:

SLIT demonstrates robust efficacy and safety for seasonal respiratory allergies.
Emerging data supports its use for perennial allergens and asthma.
Newer formulations aim to enhance SLIT safety and effectiveness.

Conclusions:

SLIT is a well-established and growing treatment for respiratory allergies.
Further research is required to identify optimal candidates and biomarkers for SLIT.
Addressing compliance barriers is crucial for maximizing SLIT benefits.